Vax Patent Battles Heat Up As Attention On Pandemic Wanes
By Ryan Davis · August 20, 2024, 5:33 PM EDT
Already a subscriber? Click here to login
Analysis
By Ryan Davis · August 20, 2024, 5:33 PM EDT
Already a subscriber? Click here to login
Arbutus Biopharma Corporation et al v. Moderna, Inc. et al
Delaware
Patent
February 28, 2022
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc., et al
Delaware
Patent
March 17, 2022
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al
Delaware
Patent
March 17, 2022
ModernaTX, Inc. et al v. Pfizer Inc. et al
Massachusetts
Patent
August 26, 2022
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
New Jersey
Patent
April 04, 2023
ARBUTUS PHARMA CORP. et al v. PFIZER INC. et al
New Jersey
Patent
April 04, 2023
CureVac SE, et al. v. BioNTech SE, et al.
Virginia Eastern
Patent
May 19, 2023
Alnylam Pharmaceuticals, Inc. v. Pfizer Inc. et al
Delaware
Patent
May 26, 2023
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
Delaware
Patent
May 26, 2023
Alnylam Pharmaceuticals, Inc. v. Moderna, Inc.
Appellate - Federal Circuit
830 Patent Infringement (Fed. Qst.)
September 07, 2023
GlaxoSmithKline Biologicals SA et al v. Pfizer Inc. et al
Delaware
Patent
April 25, 2024
Acuitas Therapeutics Inc. et al v. Alnylam Pharmaceuticals, Inc.
Delaware
Patent
July 12, 2024
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA v. BIONTECH SE et al
Pennsylvania Eastern
Contract: Other
August 05, 2024
March 19, 2026
Apple Watch Redesign Gets Early OK As Patent Loss UpheldMarch 10, 2026
Justices Advised To Keep Law Clear In 'Skinny Label' CaseFebruary 26, 2026
Justices Told 'Skinny Label' Case Puts Generic Drugs At RiskJanuary 20, 2026
Justices To Clarify What's Fair Game With 'Skinny Labels'January 16, 2026
Supreme Court Takes On Hikma's 'Skinny Label' Patent CaseDecember 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'December 19, 2025
Squires Issues 21 More Patent Review DenialsDecember 10, 2025
Apple Tells Fed. Circ. ITC Move Boosts Watch Case AppealDecember 03, 2025
USPTO Gets Earful On Plan To Restrict Patent ReviewsOctober 30, 2025
Fed. Circ. Explains Rule While Upholding Merck PTAB Loss